Author Correction: Computationally designed antibody-drug conjugates self-assembled via affinity ligands.

Journal

Nature biomedical engineering
ISSN: 2157-846X
Titre abrégé: Nat Biomed Eng
Pays: England
ID NLM: 101696896

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 5 1 2020
medline: 5 1 2020
entrez: 5 1 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41551-019-0511-3 PMID: 31900467
pubmed: 31900467
doi: 10.1038/s41551-019-0511-3
pii: 10.1038/s41551-019-0511-3
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

131

Commentaires et corrections

Type : ErratumFor

Auteurs

Nimish Gupta (N)

Akamara Therapeutics, Cambridge, MA, USA. nimishgupta@gmail.com.
Akamara Biomedicine Private Limited, Delhi, India. nimishgupta@gmail.com.
India Innovation Research Center, Delhi, India. nimishgupta@gmail.com.
Symbiosis International (Deemed University), Pune, India. nimishgupta@gmail.com.
ORCID: 0000-0002-9857-1025

Aasif Ansari (A)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Gaurao V Dhoke (GV)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Maheshwerreddy Chilamari (M)

Indian Institute of Science Education and Research Bhopal, Bhopal, India.

Jwala Sivaccumar (J)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Smita Kumari (S)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Snigdha Chatterjee (S)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Ravinder Goyal (R)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Pradip Kumar Dutta (PK)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Mallik Samarla (M)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Madhumita Mukherjee (M)

Indian Institute of Science Education and Research Bhopal, Bhopal, India.
ORCID: 0000-0001-7308-9606

Arindam Sarkar (A)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.
India Innovation Research Center, Delhi, India.

Swadhin K Mandal (SK)

Indian Institute of Science Education and Research Kolkata, Mohanpur, India.

Vishal Rai (V)

Indian Institute of Science Education and Research Bhopal, Bhopal, India.
ORCID: 0000-0002-6078-3516

Goutam Biswas (G)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.
ORCID: 0000-0002-1488-2003

Aniruddha Sengupta (A)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.
India Innovation Research Center, Delhi, India.

Sudip Roy (S)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.

Monideepa Roy (M)

Akamara Therapeutics, Cambridge, MA, USA.
Akamara Biomedicine Private Limited, Delhi, India.
India Innovation Research Center, Delhi, India.
Symbiosis International (Deemed University), Pune, India.

Shiladitya Sengupta (S)

Center for Engineered Therapeutics, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, USA. ssengupta2@bwh.harvard.edu.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA. ssengupta2@bwh.harvard.edu.
Dana-Farber Cancer Institute, Boston, MA, USA. ssengupta2@bwh.harvard.edu.
ORCID: 0000-0002-8065-5052

Classifications MeSH